Unveiling Novel Molecular Candidate Targets of Loratadine, Raloxifene, and Sorafenib in Hepatocellular Carcinoma.

Villarruel-Melquiades F, Noyola-Díaz M, Martínez-Gudiño G, Mendoza-Garrido ME, García-Sánchez JR, Bañuelos C, Pérez-Carreón JI, Camacho J

Open source

DOI: 10.3390/ijms27198648
Published: 2026 Sep 27
Container: International journal of molecular sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ijms27198648,
  title = {Unveiling Novel Molecular Candidate Targets of Loratadine, Raloxifene, and Sorafenib in Hepatocellular Carcinoma.},
  author = {Villarruel-Melquiades F and Noyola-Díaz M and Martínez-Gudiño G and Mendoza-Garrido ME and García-Sánchez JR and Bañuelos C and Pérez-Carreón JI and Camacho J},
  year = {2026},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms27198648},
  url = {https://doi.org/10.3390/ijms27198648}
}

RIS

TY  - JOUR
TI  - Unveiling Novel Molecular Candidate Targets of Loratadine, Raloxifene, and Sorafenib in Hepatocellular Carcinoma.
AU  - Villarruel-Melquiades F
AU  - Noyola-Díaz M
AU  - Martínez-Gudiño G
AU  - Mendoza-Garrido ME
AU  - García-Sánchez JR
AU  - Bañuelos C
AU  - Pérez-Carreón JI
AU  - Camacho J
PY  - 2026
JO  - International journal of molecular sciences
DO  - 10.3390/ijms27198648
UR  - https://doi.org/10.3390/ijms27198648
ER  -

APA

F, V., M, N., G, M., ME, M., JR, G., C, B., JI, P., & J, C. (2026). Unveiling Novel Molecular Candidate Targets of Loratadine, Raloxifene, and Sorafenib in Hepatocellular Carcinoma.. International journal of molecular sciences. https://doi.org/10.3390/ijms27198648

Source records

pubmed · retrieved 2026-11-11T01:44:46.642Z